Citation: Zhao Sen, Li Chunpu, Xu Bin, Liu Hong. Cp*Rh(Ⅲ)-Catalyzed C—H 3, 3-Difluoroallylation of Indoles and N-Iodosuccinimide-Mediated Cyclization for the Synthesis of Fluorinated 3, 4-Dihydropyrimido-[1, 6-a]-indol-1(2H)-one Derivatives[J]. Chinese Journal of Organic Chemistry, ;2020, 40(6): 1549-1562. doi: 10.6023/cjoc202004039 shu

Cp*Rh(Ⅲ)-Catalyzed C—H 3, 3-Difluoroallylation of Indoles and N-Iodosuccinimide-Mediated Cyclization for the Synthesis of Fluorinated 3, 4-Dihydropyrimido-[1, 6-a]-indol-1(2H)-one Derivatives

  • Corresponding author: Xu Bin, xubin@shu.edu.cn Liu Hong, hliu@simm.ac.cn
  • Received Date: 25 April 2020
    Revised Date: 30 April 2020
    Available Online: 5 May 2020

    Fund Project: the Strategic Priority Research Program of the Chinese Academy of Sciences XDA12050411the National Natural Science Foundation of China 81220108025the National Natural Science Foundation of China 91229204the National Natural Science Foundation of China 81620108027the Strategic Priority Research Program of the Chinese Academy of Sciences XDA12020375the National Natural Science Foundation of China 21632008Project supported by the National Natural Science Foundation of China (Nos. 81620108027, 21632008, 91229204, 81220108025) and the Strategic Priority Research Program of the Chinese Academy of Sciences (Nos. XDA12020375, XDA12050411)

Figures(6)

  • A mild and facile two-step strategy has been developed for the synthesis of fluorinated 3, 4-dihydropyrimido-[1, 6-a]-indol-1(2H)-ones through Cp*Rh(Ⅲ)-catalyzed C-H 3, 3-difluoroallylation and N-iodosuccinimide (NIS)-mediated cyclization. This strategy featured broad synthetic generality, unique versatility and high efficiency, which provided a potential tool for the construction of fluorine-containing heterocycles for drug discovery.
  • 加载中
    1. [1]

      (a) Mizuta, M.; Seio, K.; Miyata, K.; Sekine, M. J. Org. Chem. 2007, 72, 5046.
      (b) Bandurco, V. T.; Wong, E. M.; Levine, S. D.; Hajos, Z. G. J. Med. Chem. 1981, 24, 1455.
      (c) Hammer, H.; Winterfeldt, E. Tetrahedron 1981, 37, 3609.
      (d) Kato, M.; Nishino, S.; Iro, K.; Yamakuni, H.; Takasugi, H. Chem. Pharm. Bull. 1994, 42, 2556.
      (e) Wright, W. B.; Brabander, H. J. J. Med. Chem. 1968, 11, 1164.

    2. [2]

      (a) Zhang, Y.; Zheng, J.; Cui, S. J. Org. Chem. 2014, 79, 6490.
      (b) Zheng, J.; Zhang, Y.; Cui, S. Org. Lett. 2014, 16, 3560.
      (c) Chen, X.; Hu, X.; Bai, S.; Deng, Y.; Jiang, H.; Zeng, W. Org. Lett. 2016, 18, 192.

    3. [3]

      (a) Muller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881.
      (b) Hagmann, W. K. J. Med. Chem. 2008, 51, 4359.
      (c) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev. 2008, 37, 320.
      (d) Wang, J.; Sánchez-Roselló, M.; Aceña, J. L.; del Pozo, C.; Sorochinsky, A. E.; Fustero, S.; Soloshonok, V. A.; Liu, H. Chem. Rev. 2014, 114, 2432.
      (e) Zhou, Y.; Wang, J.; Gu, Z.; Wang, S.; Zhu, W.; Aceña, J. L.; Soloshonok, V. A.; Izawa, K.; Liu, H. Chem. Rev. 2016, 116, 422.

    4. [4]

      (a) Price, D. A.; Armour, D.; de Groot, M.; Leishman, D.; Napier, C.; Perros, M.; Stammen, B. L.; Wood, A. Bioorg. Med. Chem. Lett. 2006, 16, 4633.
      (b) Xue, F.; Li, H.; Delker, S. L.; Fang, J.; Martásek, P.; Roman, L. J.; Poulos, T. L.; Silverman, R. B. J. Am. Chem. Soc. 2010, 132, 14229.
      (c) Zhou, Q.; Ruffoni, A.; Gianatassio, R.; Fujiwara, Y.; Sella, E.; Shabat, D.; Baran, P. S. Angew. Chem., Int. Ed. 2013, 52, 3949.
      (d) Massa, M. A.; Spangler, D. P.; Durley, R. C.; Hickory, B. S.; Connolly, D. T.; Witherbee, B. J.; Smith, M. E.; Sikorski, J. A. Bioorg. Med. Chem. Lett. 2001, 11, 1625.

    5. [5]

      Middleton, W. J.; Bingham, E. M. J. Org. Chem. 1980, 45, 2883.  doi: 10.1021/jo01302a025

    6. [6]

      (a) Fujita, T.; Sugiyama, K.; Sanada, S.; Ichitsuka, T.; Ichikawa, J. Org. Lett. 2016, 18, 248.
      (b) S. Akiyama, S.; Kubota, K.; Mikus, M. S.; Paioti, P. H. S.; Romiti, F.; Liu, Q.; Zhou, Y.; Hoveyda, A. H.; Ito, H. Angew. Chem., Int. Ed. 2019, 58, 11998.
      (c) Cogswell, T. J.; Dahlen A.; Knerr, L. Chem.-Eur. J. 2019, 25, 1184.

    7. [7]

      Min, Q. Q.; Yin, Z.; Feng, Z.; Guo, W. H.; Zhang, X. J. Am. Chem. Soc. 2014, 136, 1230.  doi: 10.1021/ja4114825

    8. [8]

      Li, C.; Zhang, D.; Zhu, W.; Wan, P.; Liu, H. Org. Chem. Front. 2016, 3, 1080.  doi: 10.1039/C6QO00178E

    9. [9]

      Ni, J.; Zhao, H.; Zhang, A. Org. Lett. 2017, 19, 3159.  doi: 10.1021/acs.orglett.7b01282

    10. [10]

      (a) Wu, X.; Wang, B.; Zhou, S.; Zhou, Y.; Liu, H. ACS Catal. 2017, 7, 2494.
      (b) Wu, X.; Wang, B.; Zhou, Y.; Liu, H. Org. Lett. 2017, 19, 1294.
      (c) Xie, Y.; Wu, X.; Li, C.; Wang, J.; Li, J.; Liu, H. J. Org. Chem. 2017, 82, 5263.
      (d) Fei, X.; Li, C.; Yu X.; Liu, H. J. Org. Chem. 2019, 84, 6840.
      (e) Yang, L.; Li, C.; Wang, D.; Liu, H. J. Org. Chem. 2019, 84, 7320.

    11. [11]

      (a) Dai, H.; Yu, C.; Wang, Z.; Yan, H.; Lu, C. Org. Lett. 2016, 18, 3410.
      (b) Dutta, U.; Deb, A.; Lupton, D. W.; Maiti, D. Chem. Commun. 2015, 51, 17744.

    12. [12]

      (a) Zhang, L.; Zhu, M.; Ni, S.; Wen, L.; Li, M. ACS Catal. 2019, 9, 1680.
      (b) Kong, W.; Chen, X.; Wang, M.; Dai, H.; Yu, J. Org. Lett. 2018, 20, 284.

    13. [13]

      Nihei, T.; Iwai, N.; Matsuda, T.; Kitazume, T. J. Org. Chem. 2005, 70, 5912.  doi: 10.1021/jo050634u

  • 加载中
    1. [1]

      Xiao TangErik V. Van der EyckenLiangliang Song . Transition metal-catalyzed C-H activation/annulation for the construction of unnatural amino acids and peptides. Chinese Chemical Letters, 2026, 37(2): 111678-. doi: 10.1016/j.cclet.2025.111678

    2. [2]

      Wei-Bin LiXiao-Chao HuangPei LiuJie KongGuo-Ping Yang . Recent advances in directing group assisted transition metal catalyzed para-selective C-H functionalization. Chinese Chemical Letters, 2025, 36(6): 110543-. doi: 10.1016/j.cclet.2024.110543

    3. [3]

      Chao ChenWenwen YuGuangen HuangXuelian RenXiangli ChenYixin LiShenggui LiangMengmeng XuMingyue ZhengYaxi YangHe HuangWei TangBing Zhou . Asymmetric macrocyclization enabled by Rh(Ⅲ)-catalyzed CH activation: Enantioenriched macrocyclic inhibitor of Zika virus infection. Chinese Chemical Letters, 2024, 35(11): 109574-. doi: 10.1016/j.cclet.2024.109574

    4. [4]

      Wei Chen Pieter Cnudde . A minireview to ketene chemistry in zeolite catalysis. Chinese Journal of Structural Chemistry, 2024, 43(11): 100412-100412. doi: 10.1016/j.cjsc.2024.100412

    5. [5]

      Xiangyang JiYishuang ChenPeng ZhangShaojia SongJian LiuWeiyu Song . Boosting the first C–H bond activation of propane on rod-like V/CeO2 catalyst by photo-assisted thermal catalysis. Chinese Chemical Letters, 2025, 36(5): 110719-. doi: 10.1016/j.cclet.2024.110719

    6. [6]

      Weimei ZengYouai Qiu . Electrochemical C-H carboxylation of benzylamines. Chinese Chemical Letters, 2026, 37(1): 111679-. doi: 10.1016/j.cclet.2025.111679

    7. [7]

      Yujia ShiYan QiaoPengfei XieMiaomiao TianXingwei LiJunbiao ChangBingxian Liu . Rhodium-catalyzed enantioselective in situ C(sp3)−H heteroarylation by a desymmetrization approach. Chinese Chemical Letters, 2024, 35(10): 109544-. doi: 10.1016/j.cclet.2024.109544

    8. [8]

      Junhua LiYu FuYian Shi . A rapid access to fused polycyclic indolo[2,1-a]isoquinolins via Pd-catalyzed sequential Heck/C-H activation/amination reaction with diaziridinone. Chinese Chemical Letters, 2026, 37(3): 111376-. doi: 10.1016/j.cclet.2025.111376

    9. [9]

      Shihaozhi WangJia-Hui ShiShan XuXue-Jing ZhangMing Yan . Palladium-catalyzed carbene C-H insertion reaction of non-activated arenes. Chinese Chemical Letters, 2026, 37(4): 111225-. doi: 10.1016/j.cclet.2025.111225

    10. [10]

      Haoran ShiJiaxin WangYuqin ZhuHongyang LiGuodong JuLanlan ZhangChao Wang . Highly selective α-C(sp3)-H arylation of alkenyl amides via nickel chain-walking catalysis. Chinese Chemical Letters, 2024, 35(7): 109333-. doi: 10.1016/j.cclet.2023.109333

    11. [11]

      Xiao-Hua ChenYifan FanZitong WuTao Tu . Non-canonical bio-inspired iron catalysis for aliphatic C–H functionalization. Chinese Chemical Letters, 2026, 37(3): 112132-. doi: 10.1016/j.cclet.2025.112132

    12. [12]

      Xin-Han WangYing HuangChun-Lin ZhangSong Yeγ-C(sp3)-H acylation of aliphatic amines enabled by cooperative photoredox NHC/Pd catalysis. Chinese Chemical Letters, 2026, 37(5): 111484-. doi: 10.1016/j.cclet.2025.111484

    13. [13]

      Yi LuoLin Dong . Multicomponent remote C(sp2)-H bond addition by Ru catalysis: An efficient access to the alkylarylation of 2H-imidazoles. Chinese Chemical Letters, 2024, 35(10): 109648-. doi: 10.1016/j.cclet.2024.109648

    14. [14]

      Shulei HuYu ZhangXiong XieLuhan LiKaixian ChenHong LiuJiang Wang . Rh(Ⅲ)-catalyzed late-stage C-H alkenylation and macrolactamization for the synthesis of cyclic peptides with unique Trp(C7)-alkene crosslinks. Chinese Chemical Letters, 2024, 35(8): 109408-. doi: 10.1016/j.cclet.2023.109408

    15. [15]

      Jialin HuangLiying FuZhanyong TangXiaoqiang MaXingda ZhaoDepeng Zhao . Cross-coupling of trifluoromethylarenes with alkynes C(sp)-H bonds and azoles C(sp2)-H bonds via photoredox/copper dual catalysis. Chinese Chemical Letters, 2025, 36(7): 110505-. doi: 10.1016/j.cclet.2024.110505

    16. [16]

      Xin LiJia-Min LuBo LiChen ZhaoBei-Bei YangLi Li . Chiroptical sensing for remote chiral amines via a C–H activation reaction. Chinese Chemical Letters, 2025, 36(5): 110310-. doi: 10.1016/j.cclet.2024.110310

    17. [17]

      Yongli ZhaoDingsheng CaoJie-Ping WanYunyun Liu . Synthesis of 3-phosphinyl chromones via in situ iodination mediated C-H phosphination and the tunable synthesis of 2-phosphoryl chromanones. Chinese Chemical Letters, 2026, 37(1): 111740-. doi: 10.1016/j.cclet.2025.111740

    18. [18]

      Junmeng LuoQiongqiong WanSuming Chen . Chemistry-driven mass spectrometry for structural lipidomics at the C=C bond isomer level. Chinese Chemical Letters, 2025, 36(1): 109836-. doi: 10.1016/j.cclet.2024.109836

    19. [19]

      Qiao SongXue PengZhouyu WangLeyong Wang . Iron-catalyzed C–H activation: A sustainable approach to efficient organic synthesis. Chinese Chemical Letters, 2025, 36(5): 110869-. doi: 10.1016/j.cclet.2025.110869

    20. [20]

      Qian WangYeping BianGagan DhawanWei ZhangAlexander E. SorochinskyAta MakaremVadim A. SoloshonokJianlin Han . FDA approved fluorine-containing drugs in 2023. Chinese Chemical Letters, 2024, 35(11): 109780-. doi: 10.1016/j.cclet.2024.109780

Metrics
  • PDF Downloads(7)
  • Abstract views(1713)
  • HTML views(496)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Address:Zhongguancun North First Street 2,100190 Beijing, PR China Tel: +86-010-82449177-888
Powered By info@rhhz.net

/

DownLoad:  Full-Size Img  PowerPoint
Return